Related Experiment Video
Updated: Jan 13, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
CRYAB Missense Mutation Reveals Shared Pathogenesis of Familial Cardiomyopathy and Arrhythmia
Ali Nariman1, Mohammad Hossein Nikoo2, Nizal Sarrafzadegan3
1Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.
Insights
A novel CRYAB gene variant causes both dilated cardiomyopathy (DCM) and long QT syndrome (LQTS) in a family. This finding highlights CRYAB
Area of Science:
- Genetics
- Cardiology
- Molecular Biology
Background:
- Dilated cardiomyopathy (DCM) and long QT syndrome (LQTS) are distinct genetic heart conditions.
- Their co-occurrence in families complicates diagnosis and genetic counseling.
- Identifying shared genetic factors can reveal overlapping disease mechanisms.
Purpose of the Study:
- Investigate a family with overlapping DCM and LQTS phenotypes.
- Identify genetic variants contributing to the dual cardiac presentation.
- Understand the role of CRYAB in inherited cardiac disorders.
Main Methods:
- Exome sequencing to identify variants in a multi-generational family.
- Sanger sequencing for validation of candidate variants.
- In silico prediction and conservation analysis to assess pathogenicity.
Main Results:
- A novel heterozygous missense variant (c.368G>A, p.Arg123Gln) in the CRYAB gene was identified.
- The CRYAB variant segregated with DCM and LQTS phenotypes within the family.
- Affected individuals displayed overlapping features of both conditions.
Conclusions:
- CRYAB mutations can cause a combined DCM and LQTS phenotype.
- This expands the known spectrum of CRYAB-associated cardiac disorders.
- CRYAB should be considered in genetic testing for complex inherited cardiac conditions.
Abstract:
Background: Dilated cardiomyopathy (DCM) and long QT syndrome (LQTS) are genetically heterogeneous cardiac disorders that contribute significantly to morbidity and sudden cardiac death. Although they are typically considered distinct entities, co-occurrence within families has been increasingly recognized, complicating diagnosis and genetic counseling. Identifying shared genetic determinants may provide insights into overlapping disease mechanisms. Methods: We investigated a multi-generational family in which several members presented with features of both DCM and LQTS. Exome sequencing was performed to identify potential disease-causing variants, and candidate findings were validated by Sanger sequencing. In silico prediction tools and evolutionary conservation analysis were used to assess the pathogenic potential of the identified variant. Results: We identified a novel heterozygous missense variant in the CRYAB gene, c.368G>A (p.Arg123Gln). This variant is located in a highly conserved region critical for protein function and was consistently predicted to be deleterious across multiple computational algorithms. Segregation analysis demonstrated co-occurrence of the variant with disease phenotypes in affected family members. Clinically, several carriers exhibited overlapping features of both DCM and prolonged QT interval, suggesting a dual cardiac phenotype associated with this mutation. Conclusions: Our findings expand the phenotypic spectrum associated with CRYAB mutations, linking them to a combined presentation of dilated cardiomyopathy and long QT syndrome. This underscores the importance of including CRYAB in comprehensive gene panels for inherited cardiac disorders and highlights the need for integrated clinical and genetic evaluation in families presenting with complex cardiac phenotypes.
More Related Videos
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy

